All posts by: Michael Zand

Combination immunotherapy effective for advanced prostate cancer – Science Daily

Combination immunotherapy effective for advanced prostate cancerScience DailyCombination immunotherapy effective for advanced prostate cancer. Date: March 9, 2017; Source: University of Texas M. D. Anderson Cancer Center; Summary: Advanced prostate can… Continue reading

CAR T-Cell Therapy Has High Response Rate in Non-Hodgkin Lymphoma – Curetoday.com

Curetoday.comCAR T-Cell Therapy Has High Response Rate in Non-Hodgkin LymphomaCuretoday.comJCAR017, a CAR T-cell therapy, had a high objective response rate (80 percent), including a complete response rate of 60 percent for patients with relapsed or re… Continue reading

Preview: Immunotherapy – CBS News

CBS News

Preview: Immunotherapy CBS News March 11, 2017, 1:29 PM | Dr. Jon LaPook introduces us to the next frontier of cancer treatment: Immunotherapy, in which the body’s own immune system is modified to fight cancer. Don’t miss his report on “Beyond Cancer,” a special broadcast of “Sunday … Dr. Jon LaPook Hosts ‘Beyond Cancer’ Edition of CBS Sunday …TVNewser ‘CBS Sunday Morning,’ CNN offer health specials – Orlando SentinelOrlando Sentinel Exploring new frontiers in cancer treatmentYahoo News all 6 news articles »

Multiple Sclerosis News Today

aHSCT – Autologous Hemopoietic Stem Cell Transplantation in MS Multiple Sclerosis News Today After immunoablation is complete, the collected stem cells are then re-infused to reconstitute the immune system and re-activate it. The intended result of the therapy is to return the immune system to a functional state so that the body’s autoimmune …

CBS News

Morning Rounds: Arthritis, immunotherapy and strokes CBS News Also: CBS News chief medical correspondent Dr. Jon LaPook also previews his “Sunday Morning” report on immunotherapy, which harnesses the body’s own immune system to find and destroy cancer cells; and CBS News contributor Dr. Tara Narula reports … and more »

OHSU gene therapy studies offer hope – and vision – to patients with eye disease KATU Rods we use at nighttime and in dim light, cones are what we use during the daytime and for our color vision, says Dr. Mark Pennesi, OHSU Associate Professor of Ophthalmology who’s now treating Bretana for the disease with gene therapy.